Predicting the prevalence of chronic kidney disease in the English population: A cross-sectional study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Kearns, Benjamin ^a   Gallagher, Hugh ^b   De Lusignan, Simon ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Association; Cardiovascular disease; Chronic kidney disease; Prevalence; Renal disease; Statistical modelling

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; SEX DIFFERENCE; UNITED KINGDOM;

CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ENGLAND; FEMALE; HUMANS; MALE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING;

EID: 84874166478     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-49     Document Type: Article

References (39)

1. National Collaborating Centre for Chronic Conditions, Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care London: Royal College of Physicians 2008
2. Department of Health, The National Service Framework for Renal Services-Part Two: Chronic Kidney Disease, Acute Renal Failure and End of Life Care London: Department of Health Renal National Service Framework Team 2005 21413194
3. Prevalence of chronic kidney disease in England: findings from the 2009 health survey for England. Roderick P, Roth M, Mindell J, J Epidemiol Commun H 2011 65 Suppl I 12
4. QOF 2010/11 data tables http://www.ic.nhs.uk/catalogue/PUB04396
5. Screening for occult renal disease (SCORED): a simple prediction model for chronic kidney disease. Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV, Arch Intern Med 2007 167 4 374 381 10.1001/archinte.167.4.374 17325299 (Pubitemid 46333938)
6. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC, J Am Soc Nephrol 2003 14 7:Suppl 2 131 S138 12819318
7. CKD in the united states: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004. Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, Norris KC, Chen SC, Qiu Y, Wang C, Li S, Vassalotti JA, Collins AJ, Am J Kidney Dis 2008 51 suppl 2 13 S20 4 18359403
8. A simple prediction score for kidney disease in the Korean population. Kwon KS, Bang H, Bomback AS, Koh DH, Yum JH, Lee JH, Lee S, Park SK, Yoo KY, Park SK, Chang SH, Lim HS, Choi JM, Kshirsagar AV, Nephrology 2012 17 3 278 284 10.1111/j.1440-1797.2011.01552.x 22171932
9. Identifying patients with chronic kidney disease from general practice computer records. de Lusignan S, Chan T, Stevens P, O'Donoghue D, Hague N, Dzregah B, Van Vlymen J, Walker M, Hilton S, Fam Pract 2005 22 3 234 241 10.1093/fampra/cmi026 15814579 (Pubitemid 40744499)
10. The QICKD study protocol: a cluster randomised trial to compare quality improvement interventions to lower systolic BP in chronic kidney disease (CKD) in primary care. de Lusignan S, Gallagher H, Chan T, Thomas N, van Vlymen J, Nation M, Jain N, Tahir A, du Bois E, Crinson I, Hague N, Reid F, Harris K, Implement Sci 2009 4 39 http://www.implementationscience.com/content/4/1/39 10.1186/1748-5908-4-39 19602233
11. Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H, Nephron Clin Pract 2010 117 213 224
12. de Lusignan S, Gallagher H, Jones S, Chan T, van Vlymen J, Tahir A, Thomas N, Jain N, Dmitrieva O, Rafi I, McGovern A, Harris K, Using audit-based education to lower systolic blood pressure in chronic kidney disease (CKD): results of the quality improvement in CKD (QICKD) trial [ISRCTN: 56023731]. Accepted for Publication Kidney International, 13th January 2013, Ref: KI-06-12-0863.R3
13. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, Ann Intern Med 2003 139 137 147 12859163
14. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Levey AS, Bosch JP, Lewis JB, Greene T, Rodgers N, Roth D, Ann Intern Med 1999 130 461 470 10075613 (Pubitemid 29135798)
15. United Kingdom National External Quality Assessment Service (UK NEQAS)-Group website http://www.ukneqas.org.uk/
16. Department of Health, A practical guide to ethnic monitoring in the NHS and social care: Annex D-Detailed breakdown of the ONS 2001 census codes for ethnic group London: Department of Heath 2007 http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/browsable/ DH-5319277
17. Communities and Neigbourhoods, Indices of Deprivation 2007 London: Department for Communities and Local Government 2007 http://webarchive. nationalarchives.gov.uk/20100410180038/http:/communities.gov.uk/communities/ neighbourhoodrenewal/deprivation/deprivation07/
18. Disparities in testing for renal function in UK primary care: cross-sectional study. de Lusignan S, Nitsch D, Belsey J, Kumarapeli P, Vamos EP, Majeed A, Millett C, Fam Pract 2011 28 6 638 646 10.1093/fampra/cmr036 21719474
19. Hosmer D, Lemeshow S, Applied Logistic Regression New York, NY: John Wiley & Sons Inc 2 2000
20. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Harrell F Jr, Lee K, Mark D, Stat Med 1996 15 4 361 387 10.1002/(SICI)1097-0258(19960229)15: 4<361::AID-SIM168>3.0.CO;2-4 8668867 (Pubitemid 26072233)
21. The role of model selection in causal inference from non-experimental data. Robins J, Greenland S, Am J Epidemiol 1986 123 3 392 402 3946386 (Pubitemid 16101143)
22. STATACORP Stata Statistical Software: Release 10 College Station, TX: StataCorp LP 2007 http://www.stata.com/support/faqs/resources/citing-software- documentation-faqs/
23. Multiple imputation of missing values: update of ice. Royston P, Stata J 2005 5 4 527 536 (Pubitemid 43708457)
24. Model selection: an integral part of inference. Buckland ST, Burnham KP, Augustin NH, Biometrics 1997 53 2 603 618 10.2307/2533961 (Pubitemid 27262222)
25. Campbell M, Statistics at Square Two: Understanding Modern Statistical Applications in Medicine Oxford, UK: Wiley 2006
26. Integrating the predictiveness of a risk marker with its performance as a classifier. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y, Am J Epidemiol 2008 167 362 368 17982157 (Pubitemid 351197592)
27. External validation of QDSCORE for predicting the 10-year risk of developing type 2 diabetes. Collins GS, Altman GS, Diabetic Med 2011 28 599 607 10.1111/j.1464-5491.2011.03237.x 21480970
28. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Zou KH, O'Malley J, Mauri L, Circulation 2007 115 654 657 10.1161/CIRCULATIONAHA.105.594929 17283280 (Pubitemid 46226175)
29. A simple algorithm to predict incident kidney disease. Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, Klemmer PJ, Mazumdar M, August PA, Arch Intern Med 2008 168 22 2466 2473 10.1001/archinte.168.22.2466 19064831
30. Predictors of new-onset kidney disease in a community based population. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D, JAMA 2004 291 7 844 849 10.1001/jama.291.7.844 14970063 (Pubitemid 38543772)
31. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Parikh N, Hwang S-J, Larson MJ, Meigs JB, Levy D, Fox CS, Arch Intern Med 2006 166 17 1884 1891 10.1001/archinte.166. 17.1884 17000946 (Pubitemid 44455172)
32. Cardiovascular disease and subsequent kidney disease. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE, Arch Intern Med 2007 167 11 1130 1136 10.1001/archinte.167.11.1130 17563020 (Pubitemid 46919815)
33. Cardiovascular disease in chronic kidney disease. Saran AM, DuBose Jnr TD, Ther Adv Cardiovasc Dis 2008 2 6 425 434 10.1177/1753944708096379 19124439
34. Scottish Intercollegiate Guidelines Network, Diagnosis and management of chronic kidney disease; a national clinical guideline Edinburgh: SIGN 2008 23422161
35. Chronic kidney disease and mortality risk: a systematic review. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX, J Am Soc Nephrol 2006 17 2034 2047 10.1681/ASN.2005101085 16738019 (Pubitemid 44036188)
36. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P, BMJ 2008 336 7659 1475 1482 10.1136/bmj.39609.449676.25 18573856 (Pubitemid 351977019)
37. Chronic kidney disease management in southeast England: a preliminary cross-sectional report from the QICKD-quality improvement in chronic kidney disease study. de Lusignan S, Chan T, Gallagher H, van Vlymaen J, Thomas N, Jain N, Tahir A, Nation M, Moore J, Reid F, Harris K, Hague N, Prim Care Cardiovasc J 2009 33 9 33 39
38. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy (RRT) incidence: an ecological study. Dhoul N, de Lusignan S, Dmitrieva O, Stevens P, O'Donoghue D, Nephrol Dial Transplant 2012 27 2 739 746 10.1093/ndt/gfr347 21677297
39. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Stevens PE, O'Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CKT, Kidney Int 2007 72 92 99 10.1038/sj.ki.5002273 17440495 (Pubitemid 47014451)